000 | 01853 a2200553 4500 | ||
---|---|---|---|
005 | 20250515005148.0 | ||
264 | 0 | _c20060523 | |
008 | 200605s 0 0 eng d | ||
022 | _a1078-8956 | ||
024 | 7 |
_a10.1038/nm1320 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSablina, Anna A | |
245 | 0 | 0 |
_aThe antioxidant function of the p53 tumor suppressor. _h[electronic resource] |
260 |
_bNature medicine _cDec 2005 |
||
300 |
_a1306-13 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _a8-Hydroxy-2'-Deoxyguanosine |
650 | 0 | 4 |
_aAcetylcysteine _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xphysiology |
650 | 0 | 4 | _aBlotting, Northern |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p21 _xmetabolism |
650 | 0 | 4 | _aDNA Damage |
650 | 0 | 4 | _aDNA Primers |
650 | 0 | 4 |
_aDeoxyguanosine _xanalogs & derivatives |
650 | 0 | 4 |
_aGene Expression Regulation _xphysiology |
650 | 0 | 4 | _aGenetic Vectors |
650 | 0 | 4 |
_aGenomic Instability _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKaryotyping |
650 | 0 | 4 | _aLentivirus |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 | _aMutagenesis |
650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 |
_aSpleen _xmetabolism |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
700 | 1 | _aBudanov, Andrei V | |
700 | 1 | _aIlyinskaya, Galina V | |
700 | 1 | _aAgapova, Larissa S | |
700 | 1 | _aKravchenko, Julia E | |
700 | 1 | _aChumakov, Peter M | |
773 | 0 |
_tNature medicine _gvol. 11 _gno. 12 _gp. 1306-13 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/nm1320 _zAvailable from publisher's website |
999 |
_c15911244 _d15911244 |